Price $21.74 |
Market Cap
22.68B
|
Sector Health Care |
Div. Growth
-87.50%
|
|
P/E
-
|
P/B
1.55
|
P/S
1.05
|
Dividend %
3.90%
|
|
P/CF
17.4
|
P/FCF
7.4
|
Op. Cash Flow
3.95M
|
FCF
2.9
|
|
Op. Margin
-53.90%
|
Net Margin
-49.20%
|
ROE
-60.40%
|
ROI
-36.00%
|
|
ROA
-14.00%
|
EPS Growth
-67.40%
|
Current Ratio
0.9
|
Debt/Equity
210.00%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Quorum Health Corp (QHC) | $4.01 | - | - | 167.7M | Strong Buy |
| Assertio Therapeutics Inc (ASRT) | $5.57 | - | - | 371.4M | Strong Buy |
| InfuSystem Holdings Inc (INFU) | $3.20 | - | - | 65M | Strong Buy |
| Imprimis Pharmaceuticals Inc (IMMY) | $3.30 | - | - | 58.7M | Strong Buy |
| American Renal Associates Hold (ARA) | $19.40 | - | - | 702.9M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
